Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell Carcinoma.

actinic elastosis histopathology keratinocyte cancer non-melanoma skin cancer occupational disease

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
17 Mar 2023
Historique:
received: 06 02 2023
revised: 13 03 2023
accepted: 16 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

(1) Background: Keratinocyte cancer (KC) is associated with exposure to ultraviolet (UV) radiation. However, data are controversial as to whether chronic UV exposure or high intermittent UV exposure are key drivers of carcinogenesis in cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC). Prolonged sun exposure of the skin causes photo-aging, which is associated with actinic elastosis, a condition characterized by the degeneration of elastin in the upper dermis, which is assessable via conventional histology. In this study, we aimed to compare the degree of actinic elastosis in different types of KC with regard to various patient characteristics. (2) Methods: We defined a semiquantitative score for the degree of actinic elastosis ranging from 0 = none to 3 = total loss of elastic fibers (basophilic degeneration). The extent was measured histometrically by two independent dermatohistopathologists in the immediate vicinity of 353 KC. The scores were merged and matched with tumor types (cSCC and BCC with subtypes), and clinical variables such as body site, sex and age. (3) Results: As expected, the degree of actinic elastosis correlated with age. However, it was significantly higher in cSCC compared to BCC irrespective of age, sex, body site and tumor subtypes. (4): Conclusions: Lifetime sun exposure may be estimated via routine histology using this scoring technique for actinic elastosis as a surrogate marker. cSCCs are more strongly associated with chronic UV exposure than BCCs, even in sun-exposed localizations such as the face.

Identifiants

pubmed: 36983966
pii: life13030811
doi: 10.3390/life13030811
pmc: PMC10055681
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : KD is a collegiate member of the "Else-Kröner-Fresenius-Stiftung" and member of "BZKF Young Scientist Fellowship".
ID : xxx

Références

J Natl Cancer Inst. 2003 Jun 4;95(11):806-12
pubmed: 12783935
Sci Rep. 2021 Feb 22;11(1):4337
pubmed: 33619293
J Dtsch Dermatol Ges. 2014 Dec;12(12):1102-6
pubmed: 25482691
Hautarzt. 2022 Apr;73(4):251-256
pubmed: 35146544
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2932-41
pubmed: 20802019
G Ital Dermatol Venereol. 2020 Apr;155(2):179-189
pubmed: 29683288
Skin Pharmacol Physiol. 2015;28(6):281-9
pubmed: 26302873
J Occup Environ Med. 2018 Jan;60(1):36-43
pubmed: 29111985
Pigment Cell Res. 2004 Jun;17(3):225-9
pubmed: 15140067
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1483-9
pubmed: 23833126
Curr Probl Dermatol. 2007;34:87-97
pubmed: 17312359
Am J Dermatopathol. 2010 Aug;32(6):533-40
pubmed: 20526171
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):134-42
pubmed: 24684198
Br J Cancer. 1996 Jun;73(11):1447-54
pubmed: 8645596
J Occup Med Toxicol. 2020 Sep 10;15:28
pubmed: 32944060
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Am J Epidemiol. 2007 May 15;165(10):1162-9
pubmed: 17337756
Anticancer Res. 2006 Nov-Dec;26(6C):4979-83
pubmed: 17214374
Br J Dermatol. 2018 Feb;178(2):462-472
pubmed: 28845516
Lab Invest. 2017 Feb;97(2):187-193
pubmed: 27892931
JCO Glob Oncol. 2023 Feb;9:e2200338
pubmed: 36812449
Am J Clin Pathol. 2007 Aug;128(2):260-4
pubmed: 17638660
Med Hypotheses. 2014 Jun;82(6):652-3
pubmed: 24709066
Int J Cancer. 1991 Jul 9;48(5):650-62
pubmed: 2071226
Acta Derm Venereol. 2017 Jul 6;97(7):830-833
pubmed: 28358170
Arch Dermatol. 1997 May;133(5):593-6
pubmed: 9158412
J Am Acad Dermatol. 1984 May;10(5 Pt 1):755-9
pubmed: 6725671
J Am Acad Dermatol. 1995 Jun;32(6):1016-24
pubmed: 7751446
Adv Ther. 2021 Nov;38(11):5548-5556
pubmed: 34596866
Dermatology. 2001;202(4):289-92
pubmed: 11455139
Cancer Lett. 2007 Sep 18;255(1):1-11
pubmed: 17382466
Br J Dermatol. 2006 Sep;155(3):561-9
pubmed: 16911282
Int Arch Occup Environ Health. 2010 Dec;83(8):843-54
pubmed: 20414668
J Invest Dermatol. 2007 Apr;127(4):935-44
pubmed: 17068478
BMJ. 2010 Jul 08;341:c2986
pubmed: 20616098
J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
pubmed: 11684447
Hautarzt. 2021 Jan;72(1):2-5
pubmed: 33346860
Dermatol Surg. 2009 Feb;35(2):201-6
pubmed: 19215256
Dermatol Ther. 2020 Nov;33(6):e14037
pubmed: 32691482
Int J Cancer. 2015 Jun 15;136(12):2900-11
pubmed: 25403328

Auteurs

Konstantin Drexler (K)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Hans Drexler (H)

Institute for Vocational, Social and Environmental Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.

Sigrid Karrer (S)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Michael Landthaler (M)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Sebastian Haferkamp (S)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Florian Zeman (F)

Center for Clinical Studies, University Hospital Regensburg, 93053 Regensburg, Germany.

Mark Berneburg (M)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Dennis Niebel (D)

Department of Dermatology, University Hospital Regensburg, 93053 Regensburg, Germany.

Classifications MeSH